rofecoxib: Clinical Trials

20 trials of rofecoxib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 3 terminated, 2 unknown. 20 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 320Completed 15, Terminated 3, Unknown 2
Phase 23Completed 2, Terminated 1

Follow rofecoxib: new trials by email Literature Review of rofecoxib trials Research Report on rofecoxib

Trials (filtered) newest first · largest first

All 20 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy
TRM-201 (Rofecoxib), Placebo - Hemophilic Arthropathy
Phase 3TerminatedTremeau Pharmceuticals, Inc.22021-06-022022-10-27
Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging ≥ T2N1) - A Multi-Centre Prospective Randomised Controlled Trial
Oral Vioxx (Rofecoxib) - Cancer of Stomach
Phase 3UnknownChinese University of Hong Kong2142004-10-012005-11-17
Selective COX-II Inhibitor as a Palliative Therapy in Patients With R1 or R2 Resection for Disseminated Stomach Cancer - A Multi-Centre Prospective Randomized Controlled Trial
Vioxx (Rofecoxib) - Cancer of Stomach
Phase 3UnknownChinese University of Hong Kong2062004-10-012005-12-09
Coxib-inhibition of Duodenal Polyp Growth in FAP
Rofecoxib, placebo - Duodenal Polyposis
Phase 2 / Phase 3TerminatedOslo University Hospital382003-09-012011-07-06
A Study of Two Approved Drugs in the Treatment of Post-Bunionectomy Surgery Pain (0966-234)(COMPLETED)
MK0966, rofecoxib, Comparator: diclofenac sodium, placebo - Postoperative Pain
Phase 3CompletedMerck Sharp & Dohme LLC2512003-09-012017-05-09
A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-219)
MK0966, rofecoxib, Comparator: celecoxib, placebo - Osteoarthritis
Phase 3CompletedMerck Sharp & Dohme LLC3952003-04-292017-05-09
A Study to Evaluate Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff Syndrome
MK0966; rofecoxib, Comparator: diclofenac, placebo - Pain
Phase 3TerminatedMerck Sharp & Dohme LLC2742003-04-012006-12-05
A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-220)(COMPLETED)
MK0966, rofecoxib, Comparator: celecoxib, placebo - Osteoarthritis
Phase 3CompletedMerck Sharp & Dohme LLC4132003-04-012017-05-09
Treatment With MK0966 for the Prevention of Prostate Cancer (0966-201)
rofecoxib, Comparator: placebo (unspecified) - Prostate Cancer
Phase 3CompletedMerck Sharp & Dohme LLC150002003-01-082017-05-09
Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC
gemcitabine, prolonged continuous infusion gemcitabine, cisplatin - Advanced Non-small Cell Lung Cancer
Phase 2 / Phase 3CompletedNational Cancer Institute, Naples4002003-01-012023-03-23
A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-190)(COMPLETED)
MK0966, rofecoxib, Comparator: valdecoxib, placebo - Postoperative Pain
Phase 3CompletedMerck Sharp & Dohme LLC1252002-08-012017-05-09
A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-183)
MK0966, rofecoxib, Comparator: oxycodone with acetaminophen, placebo - Postoperative Pain
Phase 3CompletedMerck Sharp & Dohme LLC2692002-06-012016-02-22
A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-182)
MK0966, rofecoxib, Comparator: oxycodone and acetaminophen - Postoperative Pain
Phase 3CompletedMerck Sharp & Dohme LLC2712002-06-012015-11-25
A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-181)(COMPLETED)
MK0966, rofecoxib, Comparator: valdecoxib - Postoperative Pain
Phase 3CompletedMerck Sharp & Dohme LLC4502002-05-012015-08-04
Effect of Rofecoxib and a Narcotic Analgesic to Treat Pain Following Arthroscopic Surgery (0966-179)(COMPLETED)
MK0966 / Duration of Treatment: 1 Days, Comparator: acetaminophen (+) hydrocodone bitartrate / Duration of Treatment: 1 Days, Comparator: placebo (unspecified) / Duration of Treatment: 1 Days - Pain, Postoperative Arthroscopy
Phase 3CompletedMerck Sharp & Dohme LLC4202002-02-012017-02-02
Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal Cancer
rofecoxib, adjuvant therapy - Colorectal Cancer
Phase 3CompletedCancer Research Campaign Clinical Trials Centre2001-02-012013-08-02
Safety of Lumiracoxib in Patients With Osteoarthritis
lumiracoxib, rofecoxib - Osteoarthritis
Phase 3CompletedNovartis3092000-12-012008-03-18
A Study to Evaluate the Effect of MK0966 (Rofecoxib) on the Recurrence of Colorectal Adenomas (0966-122)
MK0966; Rofecoxib / Duration of Treatment: 156 weeks, Placebo/ Duration of Treatment: 156 weeks - Colorectal Adenoma
Phase 3CompletedMerck Sharp & Dohme LLC25861999-12-232017-05-09
A Four-Week Study Comparing Acetaminophen Extended Release and Rofecoxib in the Treatment of Osteoarthritis of the Knee
acetaminophen, Rofecoxib - Osteoarthritis of the Knee
Phase 3CompletedJohnson & Johnson Consumer and Personal Products Worldwide4031999-10-012011-08-22
A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)
Rofecoxib, Naproxen - Alzheimer Disease
Phase 2 / Phase 3CompletedNational Institute on Aging (NIA)2009-12-11

Conditions studied

Pain, Postoperative (5)  ·  Osteoarthritis (3)  ·  Pain (3)  ·  Stomach Neoplasms (2)  ·  Alzheimer Disease (1)  ·  Arthralgia (1)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Hemophilia A (1)  ·  Osteoarthritis, Knee (1)  ·  Prostatic Neoplasms (1)  ·  Rectal Neoplasms (1)

Sponsors

Merck Sharp & Dohme LLC (11)  ·  Chinese University of Hong Kong (2)  ·  Cancer Research Campaign Clinical Trials Centre (1)  ·  Johnson & Johnson Consumer and Personal Products Worldwide (1)  ·  National Cancer Institute, Naples (1)  ·  National Institute on Aging (NIA) (1)  ·  Novartis (1)  ·  Oslo University Hospital (1)  ·  Tremeau Pharmceuticals, Inc. (1)

Countries

China (2)  ·  Italy (2)  ·  United States (2)  ·  Australia (1)  ·  Canada (1)  ·  France (1)  ·  Norway (1)  ·  Poland (1)  ·  Spain (1)  ·  Turkey (Türkiye) (1)  ·  Ukraine (1)  ·  United Kingdom (1)

Top investigators

Enders K.W. Ng, MD (2)  ·  Cesare Gridelli, M.D. (1)  ·  David J. Kerr, MD, FRCP, DSc (1)  ·  Edwin Kuffner, MD (1)  ·  Francesco Perrone, M.D., Ph.D. (1)  ·  Judith Boice, PhD (1)  ·  Leon Thal, MD (1)

Results publications

PMID 12783912, PMID 17513173, PMID 17652651, PMID 18778469, PMID 18922570, PMID 20837956, PMID 25624439, PMID 32797734